Item 7.01. Regulation FD Disclosure.
In February and March 2020, Inspire Medical Systems, Inc. (the "Company") will
be participating in various meetings with investors and analysts, and a copy of
the Company's presentation materials being used at these meetings is furnished
as Exhibit 99.1 hereto and is incorporated herein by reference. These
presentation materials are also available on the Investor Relations page of the
Company's website at https://investors.inspiresleep.com.
The information in this Current Report on Form 8-K (including Exhibit 99.1)
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that Section, nor shall it be deemed to be incorporated by
reference into any filing of the Company under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.                                             Description

99.1                     Inspire Medical Systems, Inc. Presentation, February 2020  .

104                    Cover Page Interactive Data File - the cover page XBRL tags are embedded
                       within the Inline XBRL document.



                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses